

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.50429417 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.14845996 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14845996 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93772453 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85962281 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.11170919 |
| 7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.84642466 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.84058232 |
| 9 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.80556665 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.76486411 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.76486411 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.76486411 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.76486411 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.76486411 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.76486411 |
| 16 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.71128194 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 3.64432096 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 3.63368290 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60549091 |
| 20 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.60278524 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60204286 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54708768 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.47311996 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.45577882 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.34981754 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33498758 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 3.32085049 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.32076551 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 3.30711976 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.30402731 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.27680651 |
| 32 | response to type I interferon (GO:0034340) | 3.24960149 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.24582159 |
| 34 | negative T cell selection (GO:0043383) | 3.23875606 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.18058903 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.18058903 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16519952 |
| 38 | regulation of immunoglobulin secretion (GO:0051023) | 3.14412726 |
| 39 | myeloid dendritic cell activation (GO:0001773) | 3.13986536 |
| 40 | positive regulation of isotype switching (GO:0045830) | 3.13548785 |
| 41 | thymic T cell selection (GO:0045061) | 3.13221419 |
| 42 | B cell proliferation (GO:0042100) | 3.13166140 |
| 43 | neutrophil activation (GO:0042119) | 3.13053428 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.12920310 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.07946810 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06364448 |
| 47 | regulation of vitamin metabolic process (GO:0030656) | 3.06155261 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.06102526 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 3.04275967 |
| 50 | granulocyte activation (GO:0036230) | 3.02274485 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.01184955 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00864450 |
| 53 | B cell homeostasis (GO:0001782) | 2.98885062 |
| 54 | cellular response to ethanol (GO:0071361) | 2.96230353 |
| 55 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.93787875 |
| 56 | T cell selection (GO:0045058) | 2.92575110 |
| 57 | germinal center formation (GO:0002467) | 2.91302593 |
| 58 | positive regulation of interleukin-17 production (GO:0032740) | 2.91136337 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88539025 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.88337381 |
| 61 | positive regulation of interleukin-12 production (GO:0032735) | 2.87775536 |
| 62 | histone H3-K4 trimethylation (GO:0080182) | 2.86947801 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.86720141 |
| 64 | positive regulation of B cell mediated immunity (GO:0002714) | 2.86720141 |
| 65 | natural killer cell differentiation (GO:0001779) | 2.85931900 |
| 66 | response to protozoan (GO:0001562) | 2.85319855 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 2.83424302 |
| 68 | T cell lineage commitment (GO:0002360) | 2.82596152 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.82446283 |
| 70 | mature B cell differentiation (GO:0002335) | 2.82107574 |
| 71 | glomerular visceral epithelial cell development (GO:0072015) | 2.81821862 |
| 72 | dendritic cell differentiation (GO:0097028) | 2.79501477 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 2.78188235 |
| 74 | regulation of podosome assembly (GO:0071801) | 2.77527748 |
| 75 | negative regulation of cell killing (GO:0031342) | 2.73703301 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.73703301 |
| 77 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.72636348 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72604478 |
| 79 | protein localization to endosome (GO:0036010) | 2.72590278 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70606625 |
| 81 | regulation of T-helper cell differentiation (GO:0045622) | 2.70306315 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70273432 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70191696 |
| 84 | growth hormone receptor signaling pathway (GO:0060396) | 2.68992225 |
| 85 | leukocyte aggregation (GO:0070486) | 2.67811410 |
| 86 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.67045305 |
| 87 | positive T cell selection (GO:0043368) | 2.66057670 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65691629 |
| 89 | tolerance induction (GO:0002507) | 2.65458341 |
| 90 | response to peptidoglycan (GO:0032494) | 2.63043954 |
| 91 | hepatocyte apoptotic process (GO:0097284) | 2.62940819 |
| 92 | establishment of endothelial barrier (GO:0061028) | 2.62274786 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.62095349 |
| 94 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61767585 |
| 95 | response to host (GO:0075136) | 2.59660268 |
| 96 | response to host defenses (GO:0052200) | 2.59660268 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59660268 |
| 98 | activation of MAPKKK activity (GO:0000185) | 2.59419245 |
| 99 | positive regulation of interleukin-2 production (GO:0032743) | 2.58543400 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.55193104 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53490941 |
| 102 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.53460810 |
| 103 | regulation of isotype switching (GO:0045191) | 2.53022239 |
| 104 | regulation of RIG-I signaling pathway (GO:0039535) | 2.51675166 |
| 105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.51392523 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.50282368 |
| 107 | response to interleukin-15 (GO:0070672) | 2.49070943 |
| 108 | positive regulation of DNA recombination (GO:0045911) | 2.48606815 |
| 109 | B cell mediated immunity (GO:0019724) | 2.48546021 |
| 110 | T-helper 1 type immune response (GO:0042088) | 2.48155298 |
| 111 | positive regulation of B cell activation (GO:0050871) | 2.47895442 |
| 112 | positive regulation of type 2 immune response (GO:0002830) | 2.47778476 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.46639827 |
| 114 | response to host immune response (GO:0052572) | 2.46639827 |
| 115 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.45291103 |
| 116 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45103528 |
| 117 | natural killer cell activation (GO:0030101) | 2.45021976 |
| 118 | JAK-STAT cascade (GO:0007259) | 2.43720232 |
| 119 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.43201694 |
| 120 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43039255 |
| 121 | positive regulation of humoral immune response (GO:0002922) | 2.42969630 |
| 122 | T cell migration (GO:0072678) | 2.42895631 |
| 123 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.42844523 |
| 124 | T-helper cell differentiation (GO:0042093) | 2.42844523 |
| 125 | cellular extravasation (GO:0045123) | 2.42765234 |
| 126 | regulation of chronic inflammatory response (GO:0002676) | 2.41559725 |
| 127 | endothelial tube morphogenesis (GO:0061154) | 2.41122118 |
| 128 | morphogenesis of an endothelium (GO:0003159) | 2.41122118 |
| 129 | pinocytosis (GO:0006907) | 2.41120870 |
| 130 | regulation of interleukin-17 production (GO:0032660) | 2.41106920 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.40555687 |
| 132 | detection of other organism (GO:0098543) | 2.39917810 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.39492640 |
| 134 | positive regulation of defense response to virus by host (GO:0002230) | 2.38844937 |
| 135 | cellular response to virus (GO:0098586) | 2.38429706 |
| 136 | regulation of B cell proliferation (GO:0030888) | 2.38383918 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.38278740 |
| 138 | myeloid cell activation involved in immune response (GO:0002275) | 2.37272284 |
| 139 | cellular response to interferon-gamma (GO:0071346) | 2.36928678 |
| 140 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.36891885 |
| 141 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.36837802 |
| 142 | negative regulation of bone resorption (GO:0045779) | 2.36468900 |
| 143 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.35969069 |
| 144 | cellular response to exogenous dsRNA (GO:0071360) | 2.35953624 |
| 145 | interferon-gamma production (GO:0032609) | 2.35660762 |
| 146 | positive regulation of B cell proliferation (GO:0030890) | 2.35509683 |
| 147 | glomerular epithelial cell development (GO:0072310) | 2.35418677 |
| 148 | T cell proliferation (GO:0042098) | 2.35383006 |
| 149 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.34498241 |
| 150 | regulation of B cell mediated immunity (GO:0002712) | 2.34259219 |
| 151 | detection of molecule of bacterial origin (GO:0032490) | 2.34247306 |
| 152 | regulation of germinal center formation (GO:0002634) | 2.34117162 |
| 153 | defense response to protozoan (GO:0042832) | 2.33127589 |
| 154 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.31090871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.46583180 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.02611765 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.53571746 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.03494802 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84163415 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51277512 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.46029100 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.45318832 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40783338 |
| 10 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21718780 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08661997 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.02320637 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88844861 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63770694 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62517321 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.60567952 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.59838460 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48240181 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30891839 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30358307 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23944520 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11544266 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.11221089 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.05445915 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02344391 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99851248 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97778917 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.97771747 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92616754 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.79031448 |
| 31 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78936960 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77236101 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76501056 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73966273 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71534985 |
| 36 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69522994 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66034773 |
| 38 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63042288 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61496844 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57878912 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55076786 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53528612 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53446720 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48531930 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47711067 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45536362 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42400350 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39063582 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37045116 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36105708 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33961710 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33302031 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32449652 |
| 54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31348825 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30924328 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28192585 |
| 57 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27068647 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25100353 |
| 59 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23861712 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21403441 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16129148 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16059072 |
| 63 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14079364 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14035570 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10159159 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09564695 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08930345 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08432522 |
| 69 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08285435 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06645208 |
| 71 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06119208 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06112511 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05999170 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05880985 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05467113 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05138708 |
| 77 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05138708 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04990807 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04507240 |
| 80 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01789984 |
| 81 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00418883 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99986444 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99920026 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99731093 |
| 85 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98813079 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98168594 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95836569 |
| 88 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94649443 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93585840 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92976604 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92213669 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91464092 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90744753 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89979092 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89870561 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89854775 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89821919 |
| 98 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89457776 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89087725 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88324488 |
| 101 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87034952 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86766290 |
| 103 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86304728 |
| 104 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86132232 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85440831 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85389271 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85369277 |
| 108 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85331256 |
| 109 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85331256 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84807502 |
| 111 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84577266 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.83279254 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81788125 |
| 114 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81492668 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80622778 |
| 116 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80034552 |
| 117 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79899348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.99069707 |
| 2 | MP0002254_reproductive_system_inflammat | 3.56783539 |
| 3 | MP0000685_abnormal_immune_system | 3.39376848 |
| 4 | MP0001790_abnormal_immune_system | 3.04032817 |
| 5 | MP0005387_immune_system_phenotype | 3.04032817 |
| 6 | MP0003303_peritoneal_inflammation | 2.87534146 |
| 7 | MP0005671_abnormal_response_to | 2.75891877 |
| 8 | MP0001800_abnormal_humoral_immune | 2.66342300 |
| 9 | MP0003436_decreased_susceptibility_to | 2.64031177 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.56540430 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.51339353 |
| 12 | MP0004510_myositis | 2.47023475 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.40722548 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.31538563 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.31380826 |
| 16 | MP0009785_altered_susceptibility_to | 2.31124789 |
| 17 | MP0002723_abnormal_immune_serum | 2.24873288 |
| 18 | MP0003724_increased_susceptibility_to | 2.24684241 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.20847279 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.17681047 |
| 21 | MP0005025_abnormal_response_to | 2.13120403 |
| 22 | MP0002419_abnormal_innate_immunity | 2.09301494 |
| 23 | MP0001819_abnormal_immune_cell | 2.08998895 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.07914099 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.99143763 |
| 26 | MP0008057_abnormal_DNA_replication | 1.98761582 |
| 27 | MP0002006_tumorigenesis | 1.95673698 |
| 28 | MP0004947_skin_inflammation | 1.93845465 |
| 29 | MP0005451_abnormal_body_composition | 1.93673220 |
| 30 | MP0006082_CNS_inflammation | 1.89855997 |
| 31 | MP0005310_abnormal_salivary_gland | 1.80657683 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.79553670 |
| 33 | MP0002405_respiratory_system_inflammati | 1.76109230 |
| 34 | MP0002398_abnormal_bone_marrow | 1.73386532 |
| 35 | MP0001873_stomach_inflammation | 1.73275204 |
| 36 | MP0000716_abnormal_immune_system | 1.70333308 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.63810896 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.56535208 |
| 39 | MP0001853_heart_inflammation | 1.56397774 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.56048887 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.55463986 |
| 42 | MP0006054_spinal_hemorrhage | 1.55436289 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.54163179 |
| 44 | MP0003828_pulmonary_edema | 1.54041587 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.52701325 |
| 46 | MP0000604_amyloidosis | 1.51218614 |
| 47 | MP0003950_abnormal_plasma_membrane | 1.47737372 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.46017435 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.45573511 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.42525900 |
| 51 | MP0009840_abnormal_foam_cell | 1.42426294 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.41738828 |
| 53 | MP0009278_abnormal_bone_marrow | 1.40041151 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.39855700 |
| 55 | MP0003045_fibrosis | 1.38388059 |
| 56 | MP0002429_abnormal_blood_cell | 1.33586861 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.32158447 |
| 58 | MP0001851_eye_inflammation | 1.32077829 |
| 59 | MP0002722_abnormal_immune_system | 1.30626884 |
| 60 | MP0003448_altered_tumor_morphology | 1.30008017 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.29795084 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.26463183 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.23617475 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.21552350 |
| 65 | MP0003091_abnormal_cell_migration | 1.18980888 |
| 66 | MP0002009_preneoplasia | 1.18975073 |
| 67 | MP0002933_joint_inflammation | 1.16626073 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.14756061 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.11886566 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.11886566 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.11154142 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.10924397 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.10018358 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.09087693 |
| 75 | MP0008469_abnormal_protein_level | 1.06796112 |
| 76 | MP0008004_abnormal_stomach_pH | 1.05681874 |
| 77 | MP0003866_abnormal_defecation | 1.03855043 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.03057906 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.00064946 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.97715157 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.97164995 |
| 82 | MP0003075_altered_response_to | 0.96471979 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.95942744 |
| 84 | MP0000858_altered_metastatic_potential | 0.94645925 |
| 85 | MP0000371_diluted_coat_color | 0.94210561 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.94111981 |
| 87 | MP0009764_decreased_sensitivity_to | 0.93786949 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.92619615 |
| 89 | MP0009115_abnormal_fat_cell | 0.92328673 |
| 90 | MP0003279_aneurysm | 0.89497829 |
| 91 | MP0002928_abnormal_bile_duct | 0.89209155 |
| 92 | MP0005023_abnormal_wound_healing | 0.88727055 |
| 93 | MP0005166_decreased_susceptibility_to | 0.87881843 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.87751194 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.86254409 |
| 96 | MP0000343_altered_response_to | 0.85929458 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.85818612 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.83254010 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.82584546 |
| 100 | MP0004272_abnormal_basement_membrane | 0.81509447 |
| 101 | MP0005621_abnormal_cell_physiology | 0.80274448 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.79529333 |
| 103 | MP0010307_abnormal_tumor_latency | 0.79079855 |
| 104 | MP0000249_abnormal_blood_vessel | 0.78730245 |
| 105 | MP0005164_abnormal_response_to | 0.78201431 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.77639600 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.76587606 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.76392054 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.76193443 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.76083782 |
| 111 | MP0002060_abnormal_skin_morphology | 0.76014359 |
| 112 | MP0005390_skeleton_phenotype | 0.76011145 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.74437800 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.74253751 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.72537853 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.72318474 |
| 117 | MP0000383_abnormal_hair_follicle | 0.72141370 |
| 118 | MP0005275_abnormal_skin_tensile | 0.71453762 |
| 119 | MP0003868_abnormal_feces_composition | 0.69861931 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.69394401 |
| 121 | MP0003795_abnormal_bone_structure | 0.66743748 |
| 122 | MP0001191_abnormal_skin_condition | 0.61994399 |
| 123 | MP0001915_intracranial_hemorrhage | 0.58553412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.27295090 |
| 2 | Recurrent fungal infections (HP:0002841) | 4.22685997 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.16402603 |
| 4 | Hematochezia (HP:0002573) | 4.12531297 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.08072166 |
| 6 | Recurrent viral infections (HP:0004429) | 3.80996157 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.58568211 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.58568211 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.58568211 |
| 10 | Myositis (HP:0100614) | 3.50515298 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49538156 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49538156 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.46832321 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.46360671 |
| 15 | Chronic otitis media (HP:0000389) | 3.40514051 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37484662 |
| 17 | Colitis (HP:0002583) | 3.34467398 |
| 18 | Increased IgE level (HP:0003212) | 3.33310383 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30038332 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.29138789 |
| 21 | Vasculitis (HP:0002633) | 3.23378005 |
| 22 | Orchitis (HP:0100796) | 3.21283752 |
| 23 | Cellulitis (HP:0100658) | 3.16583334 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.16361752 |
| 25 | Abnormality of the fingertips (HP:0001211) | 3.14876242 |
| 26 | Recurrent skin infections (HP:0001581) | 3.05480248 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00232566 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 2.96107163 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.93250896 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.91929392 |
| 31 | Optic neuritis (HP:0100653) | 2.91929392 |
| 32 | Periodontitis (HP:0000704) | 2.90635750 |
| 33 | Inflammation of the large intestine (HP:0002037) | 2.89763816 |
| 34 | Pulmonary infiltrates (HP:0002113) | 2.88723774 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.88027489 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.83673537 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.79095738 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.74074772 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.71371933 |
| 40 | Meningitis (HP:0001287) | 2.67024387 |
| 41 | Gingivitis (HP:0000230) | 2.66650732 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.62473294 |
| 43 | Pustule (HP:0200039) | 2.61009378 |
| 44 | Eosinophilia (HP:0001880) | 2.56800282 |
| 45 | Emphysema (HP:0002097) | 2.54978928 |
| 46 | Increased IgM level (HP:0003496) | 2.54400868 |
| 47 | Nasal polyposis (HP:0100582) | 2.52481561 |
| 48 | Arterial thrombosis (HP:0004420) | 2.51990687 |
| 49 | Hemoptysis (HP:0002105) | 2.45121073 |
| 50 | Gastrointestinal stroma tumor (HP:0100723) | 2.44583610 |
| 51 | Restrictive lung disease (HP:0002091) | 2.44088484 |
| 52 | Milia (HP:0001056) | 2.42998265 |
| 53 | T lymphocytopenia (HP:0005403) | 2.41484419 |
| 54 | Osteomyelitis (HP:0002754) | 2.39215051 |
| 55 | Thoracolumbar scoliosis (HP:0002944) | 2.38714222 |
| 56 | Stomatitis (HP:0010280) | 2.34993112 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.34813932 |
| 58 | Hypergammaglobulinemia (HP:0010702) | 2.34364934 |
| 59 | Viral hepatitis (HP:0006562) | 2.33346776 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.32821721 |
| 61 | Chronic diarrhea (HP:0002028) | 2.28648985 |
| 62 | Abnormality of T cells (HP:0002843) | 2.28361149 |
| 63 | Aortic aneurysm (HP:0004942) | 2.26388893 |
| 64 | Leukocytosis (HP:0001974) | 2.26100592 |
| 65 | Spondylolisthesis (HP:0003302) | 2.22471002 |
| 66 | Esophageal varix (HP:0002040) | 2.21962495 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.20811406 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.20382818 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.18287156 |
| 70 | Thyroiditis (HP:0100646) | 2.18184142 |
| 71 | Chest pain (HP:0100749) | 2.17122000 |
| 72 | Loss of speech (HP:0002371) | 2.13695153 |
| 73 | Tetraparesis (HP:0002273) | 2.12805220 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.11395886 |
| 75 | Skin ulcer (HP:0200042) | 2.10686638 |
| 76 | IgA deficiency (HP:0002720) | 2.06364183 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.05569937 |
| 78 | IgM deficiency (HP:0002850) | 2.04121320 |
| 79 | Abnormality of the gastric mucosa (HP:0004295) | 2.03244005 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.01222515 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98883185 |
| 82 | Granulocytopenia (HP:0001913) | 1.98273455 |
| 83 | Lymphopenia (HP:0001888) | 1.97306439 |
| 84 | Papilloma (HP:0012740) | 1.94556064 |
| 85 | Verrucae (HP:0200043) | 1.94556064 |
| 86 | Dysostosis multiplex (HP:0000943) | 1.94022141 |
| 87 | Myocardial infarction (HP:0001658) | 1.92317239 |
| 88 | Premature loss of primary teeth (HP:0006323) | 1.92244260 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.91355374 |
| 90 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91355374 |
| 91 | Sepsis (HP:0100806) | 1.90789279 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 1.90601892 |
| 93 | Nephritis (HP:0000123) | 1.89584330 |
| 94 | Obstructive lung disease (HP:0006536) | 1.88960568 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88960568 |
| 96 | B lymphocytopenia (HP:0010976) | 1.88673875 |
| 97 | Abnormality of B cell number (HP:0010975) | 1.88673875 |
| 98 | Disinhibition (HP:0000734) | 1.88377394 |
| 99 | Lip pit (HP:0100267) | 1.88249253 |
| 100 | Thick nail (HP:0001805) | 1.88150702 |
| 101 | Basal ganglia calcification (HP:0002135) | 1.86626082 |
| 102 | Recurrent sinusitis (HP:0011108) | 1.86144395 |
| 103 | Apathy (HP:0000741) | 1.85532195 |
| 104 | Vascular tortuosity (HP:0004948) | 1.84838540 |
| 105 | Polycythemia (HP:0001901) | 1.84468387 |
| 106 | Recurrent pneumonia (HP:0006532) | 1.84035490 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 1.83483436 |
| 108 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83390906 |
| 109 | Persistence of primary teeth (HP:0006335) | 1.83191852 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.82741575 |
| 111 | Arterial tortuosity (HP:0005116) | 1.82736500 |
| 112 | Fatigue (HP:0012378) | 1.81873504 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.81846766 |
| 114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81511341 |
| 115 | Chronic sinusitis (HP:0011109) | 1.80564617 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79976376 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79976376 |
| 118 | Dysmetric saccades (HP:0000641) | 1.79429235 |
| 119 | Lymphedema (HP:0001004) | 1.79388790 |
| 120 | Glomerulonephritis (HP:0000099) | 1.77766198 |
| 121 | Cutis marmorata (HP:0000965) | 1.77278656 |
| 122 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.76995380 |
| 123 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76389160 |
| 124 | Diminished motivation (HP:0000745) | 1.75254862 |
| 125 | Cubitus valgus (HP:0002967) | 1.71731460 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71627282 |
| 127 | Hepatitis (HP:0012115) | 1.69707729 |
| 128 | Bladder carcinoma (HP:0002862) | 1.69243470 |
| 129 | Bladder neoplasm (HP:0009725) | 1.69243470 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68852241 |
| 131 | Abnormality of the periventricular white matter (HP:0002518) | 1.67657606 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67597922 |
| 133 | Thin bony cortex (HP:0002753) | 1.66839219 |
| 134 | Broad face (HP:0000283) | 1.65910723 |
| 135 | Lymphoma (HP:0002665) | 1.64687045 |
| 136 | Arthralgia (HP:0002829) | 1.63799611 |
| 137 | Cupped ribs (HP:0000887) | 1.63273754 |
| 138 | Anhidrosis (HP:0000970) | 1.63154680 |
| 139 | Flat acetabular roof (HP:0003180) | 1.63041307 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.61248892 |
| 141 | Slow saccadic eye movements (HP:0000514) | 1.61011657 |
| 142 | Acrocyanosis (HP:0001063) | 1.60990328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.75269673 |
| 2 | MAP4K1 | 3.60952720 |
| 3 | MAP3K14 | 3.52724066 |
| 4 | TYK2 | 3.17541381 |
| 5 | TGFBR2 | 2.92316002 |
| 6 | JAK3 | 2.81291259 |
| 7 | ERN1 | 2.60545108 |
| 8 | TBK1 | 2.36773428 |
| 9 | JAK1 | 2.29861264 |
| 10 | FGFR4 | 2.10935185 |
| 11 | EPHA3 | 2.08025873 |
| 12 | IKBKE | 2.02667807 |
| 13 | DDR2 | 1.97867585 |
| 14 | STK10 | 1.96369116 |
| 15 | BLK | 1.95565266 |
| 16 | FGFR3 | 1.92120068 |
| 17 | IKBKB | 1.91698765 |
| 18 | CHUK | 1.90931678 |
| 19 | MAP3K13 | 1.88771576 |
| 20 | MAPK15 | 1.82826901 |
| 21 | EPHB1 | 1.75085042 |
| 22 | ZAP70 | 1.74346269 |
| 23 | IRAK4 | 1.67288261 |
| 24 | TXK | 1.67046641 |
| 25 | KIT | 1.65362653 |
| 26 | ITK | 1.63060420 |
| 27 | CSK | 1.61007276 |
| 28 | ICK | 1.55788574 |
| 29 | CDC42BPA | 1.55425620 |
| 30 | PTK6 | 1.50857973 |
| 31 | NLK | 1.47814158 |
| 32 | RIPK4 | 1.42949806 |
| 33 | CSF1R | 1.40862403 |
| 34 | CDK12 | 1.37804268 |
| 35 | MAP3K10 | 1.32032153 |
| 36 | BTK | 1.29906938 |
| 37 | KDR | 1.26481860 |
| 38 | FGR | 1.22160808 |
| 39 | INSRR | 1.19993618 |
| 40 | SYK | 1.19759600 |
| 41 | TEC | 1.19509417 |
| 42 | HIPK2 | 1.19502136 |
| 43 | HCK | 1.17487246 |
| 44 | JAK2 | 1.17223478 |
| 45 | IRAK3 | 1.16736656 |
| 46 | TGFBR1 | 1.13124780 |
| 47 | TAOK2 | 1.12798748 |
| 48 | EIF2AK3 | 1.10565907 |
| 49 | EEF2K | 1.08742942 |
| 50 | CAMK1D | 1.06049248 |
| 51 | LCK | 1.02164132 |
| 52 | MAPK11 | 0.99378453 |
| 53 | RIPK1 | 0.96976418 |
| 54 | FLT3 | 0.96168017 |
| 55 | CAMK1G | 0.93703049 |
| 56 | RPS6KA4 | 0.92978907 |
| 57 | MOS | 0.92621457 |
| 58 | NME2 | 0.92570771 |
| 59 | DMPK | 0.91947971 |
| 60 | MAP3K3 | 0.88820997 |
| 61 | TIE1 | 0.86752132 |
| 62 | MAPK7 | 0.86541414 |
| 63 | IRAK1 | 0.86043411 |
| 64 | LRRK2 | 0.85011189 |
| 65 | PIM1 | 0.81554975 |
| 66 | SMG1 | 0.77682590 |
| 67 | TAOK3 | 0.77581191 |
| 68 | CDK4 | 0.75042097 |
| 69 | PDK1 | 0.74712654 |
| 70 | YES1 | 0.74318089 |
| 71 | MATK | 0.73904698 |
| 72 | PIK3CG | 0.73088046 |
| 73 | STK24 | 0.72054332 |
| 74 | CDK6 | 0.71729517 |
| 75 | LYN | 0.70733263 |
| 76 | MARK3 | 0.69201065 |
| 77 | MAPK4 | 0.68864720 |
| 78 | MAP3K1 | 0.68782085 |
| 79 | CDK9 | 0.67870204 |
| 80 | MAP2K3 | 0.67346601 |
| 81 | SGK3 | 0.65813965 |
| 82 | MARK2 | 0.65206099 |
| 83 | MTOR | 0.64884905 |
| 84 | IRAK2 | 0.64760829 |
| 85 | PIM2 | 0.64513270 |
| 86 | TRIB3 | 0.62886379 |
| 87 | GRK7 | 0.62792986 |
| 88 | RPS6KB2 | 0.62640240 |
| 89 | LATS1 | 0.61121734 |
| 90 | SIK3 | 0.60338844 |
| 91 | MAPK12 | 0.59869476 |
| 92 | KSR2 | 0.59787208 |
| 93 | PDGFRB | 0.59463229 |
| 94 | MAPKAPK2 | 0.58819522 |
| 95 | WNK1 | 0.58223451 |
| 96 | PDPK1 | 0.57731420 |
| 97 | TTN | 0.57383839 |
| 98 | PRKCH | 0.56538779 |
| 99 | CLK1 | 0.56012994 |
| 100 | AKT3 | 0.55759442 |
| 101 | GRK6 | 0.55676607 |
| 102 | PRKCQ | 0.55664954 |
| 103 | SIK1 | 0.55647074 |
| 104 | FES | 0.55481861 |
| 105 | SGK2 | 0.54020556 |
| 106 | MAPKAPK3 | 0.53162187 |
| 107 | MELK | 0.52456010 |
| 108 | TYRO3 | 0.50325842 |
| 109 | NEK9 | 0.50202969 |
| 110 | PRKAA2 | 0.50007094 |
| 111 | ABL1 | 0.49756774 |
| 112 | RPS6KL1 | 0.49429436 |
| 113 | RPS6KC1 | 0.49429436 |
| 114 | SIK2 | 0.49395784 |
| 115 | DYRK1B | 0.48657124 |
| 116 | EGFR | 0.46778576 |
| 117 | PKN2 | 0.46637821 |
| 118 | RPS6KA2 | 0.46465506 |
| 119 | MAP3K11 | 0.45181850 |
| 120 | MAP3K7 | 0.44999480 |
| 121 | TRPM7 | 0.43519889 |
| 122 | FRK | 0.42829440 |
| 123 | BMPR2 | 0.42508760 |
| 124 | ARAF | 0.42481709 |
| 125 | RET | 0.42101542 |
| 126 | PRKD1 | 0.41286201 |
| 127 | STK3 | 0.40823833 |
| 128 | BRD4 | 0.40086407 |
| 129 | PRKD2 | 0.39417567 |
| 130 | MAP3K5 | 0.38663881 |
| 131 | PDGFRA | 0.38504103 |
| 132 | TAOK1 | 0.36555984 |
| 133 | INSR | 0.36423784 |
| 134 | STK4 | 0.35964012 |
| 135 | PAK4 | 0.35933997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54922638 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54255909 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53851561 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32092193 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19035271 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.02028336 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00782948 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96493492 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96197964 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94085955 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.86173611 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81000741 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80935388 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.78073054 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64482638 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62172376 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.57457435 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56361783 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55451156 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51610197 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49826516 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48678682 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.44215837 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43705186 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42721240 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.40001807 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39623531 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.38817449 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35603802 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.34624682 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34595624 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.33826680 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.33617117 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32589672 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31089919 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24475925 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.22871578 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22844170 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22669260 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19119607 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18920245 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18458100 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16792210 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12354218 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07634677 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.06549586 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.06157873 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04074817 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.03393078 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.03036826 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.02462467 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00769747 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98329906 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.93498571 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91879728 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90999772 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.90387100 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.89645247 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89448552 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88784149 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86887161 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86065110 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.83230661 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82694747 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.82479404 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82416243 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.78867592 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78055887 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77116338 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.74935038 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73577816 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72464301 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71612943 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70483259 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70337059 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.68830445 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67088316 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.66446685 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65307243 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.65232939 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64331778 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64089879 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63511710 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62602980 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61136698 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60765354 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60305274 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59583589 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59331613 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59182589 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57411830 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56862972 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56504124 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56286496 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55324800 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55185457 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53727637 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50413318 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50233278 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49809231 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49553529 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49412683 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48547851 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47953597 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47496841 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.47313777 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47310829 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46883446 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44484794 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44340092 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44285677 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43798708 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42723278 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42223834 |

